3-[4-[[4-(Dimethylamino)phenyl]-[4-[4-[[[4-(dimethylamino)phenyl]-[5-(2-oxochromen-4-yl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]amino]phenyl]anilino]methyl]-5-sulfanylidene-1,3,4-oxadiazol-2-yl]chromen-2-one

InChIKey	`LUWIINFHVAGLPY-UHFFFAOYSA-N`
Compound Name	3-[4-[[4-(Dimethylamino)phenyl]-[4-[4-[[[4-(dimethylamino)phenyl]-[5-(2-oxochromen-4-yl)-2-sulfanylidene-1,3,4-oxadiazol-3-yl]methyl]amino]phenyl]anilino]methyl]-5-sulfanylidene-1,3,4-oxadiazol-2-yl]chromen-2-one
Canonical SMILES	`CN(C)c1ccc(C(Nc2ccc(-c3ccc(NC(c4ccc(N(C)C)cc4)n4nc(-c5cc(=O)oc6ccccc56)oc4=S)cc3)cc2)n2nc(-c3cc4ccccc4oc3=O)oc2=S)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	7.16
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43451	MGAM	Homo sapiens	Human	PF13802 PF01055 PF21365 PF00088	7.2	IC50	ChEMBL
P10253	GAA	Homo sapiens	Human	PF13802 PF01055 PF21365 PF00088	7.2	IC50	ChEMBL
P14410	SI	Homo sapiens	Human	PF13802 PF01055 PF21365 PF00088	7.2	IC50	ChEMBL
Q2M2H8	MGAM2	Homo sapiens	Human	PF13802 PF01055 PF21365 PF00088	7.2	IC50	ChEMBL;BindingDB